MedTrace Logo

POINT - Preventing an Opioid Epidemic in Norway: Focusing on Treatment of Chronic Pain

NCT05828121 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2023-04-25

No results posted yet for this study

Summary

The investigators do research on chronic pain treatment to minimize the risks associated with opioids.

Conditions

Interventions

BEHAVIORAL

POINT1

Receiving treatment

Sponsors & Collaborators

  • The Research Council of Norway

    collaborator OTHER

  • Helse Stavanger HF

    lead OTHER_GOV

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
67 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2024-06-01
Completion
2025-06-01

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05828121 on ClinicalTrials.gov